These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5046212)

  • 1. [The treatment of metastatic breast cancer with 5-fluorouracil].
    Zwaveling A
    Ned Tijdschr Geneeskd; 1972 Jul; 116(29):1220-3. PubMed ID: 5046212
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of successful use of 5-fluorouracil and cyclophosphane in metastasis of cancer of the breast].
    Dymarskiĭ LIu; Chernomordikova MF
    Klin Med (Mosk); 1968 Sep; 46(9):124-6. PubMed ID: 5715264
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of advanced cancer of the breast with 5-fluorouracil.
    Vansant JH; Payne RL; Wheeler JR
    Am Surg; 1971 May; 37(5):287-9. PubMed ID: 5576598
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fluorouracil for advanced breast cancer].
    Solheim OP
    Tidsskr Nor Laegeforen; 1974 Jan; 94(2):69-71. PubMed ID: 4822268
    [No Abstract]   [Full Text] [Related]  

  • 5. Moderately high-dosage methotrexate medication in metastatic breast cancer.
    Wils JA
    Neth J Med; 1980; 23(2):59-61. PubMed ID: 7374869
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant chemotherapy with chlorambucil and 5-fluorouracil in primary breast cancer (Cooperative Study Heidelberg).
    Kaufmann M; Fournier DV; Sievers H; Staib I; Wöllgens P; Nedden R; Lochbühler H; Queisser W; Christmann D; Bühner R; Pfuhl PJ; Henningsen B; Kuttig H; Wysocki S; Thüre D; Köhler C; Drings P
    Eur J Cancer (1965); 1980; Suppl 1():157-60. PubMed ID: 7032925
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.
    Chu L; Sutton LM; Peterson BL; Havlin KA; Winer EP
    J Infus Chemother; 1996; 6(4):211-6. PubMed ID: 9229318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lapatinib: new drug. For some women with metastatic breast cancer.
    Prescrire Int; 2009 Feb; 18(99):9. PubMed ID: 19382400
    [No Abstract]   [Full Text] [Related]  

  • 9. Destruction of both extensive local recurrent and primary breast cancer with topical aqueous 5-FU: a clinical observation.
    Zweig JI; Kabakow B
    Cancer Treat Rep; 1986 Jul; 70(7):936-7. PubMed ID: 3719590
    [No Abstract]   [Full Text] [Related]  

  • 10. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of metastases of breast cancer by an immediate combination of hormonal treatment and chemotherapy with nonhormonal cytostatics].
    Mannes P; Derriks R
    Acta Tuberc Pneumol Belg; 1968; 59(2):445-54. PubMed ID: 5720490
    [No Abstract]   [Full Text] [Related]  

  • 12. A new method for treatment of carcinoma of the breast and colon with 5-fluorouracil.
    Van Way CW; Reynolds VH
    Am Surg; 1970 Apr; 36(4):210-8. PubMed ID: 5436101
    [No Abstract]   [Full Text] [Related]  

  • 13. Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study.
    Pannuti F; Rossi AP; Di Marco AR; Fruet F; Lelli G; Strocchi E; Rocchetta G; Piana E; Martoni A
    Panminerva Med; 1981; 23(1):25-8. PubMed ID: 7290722
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of breast cancer].
    Wilmanns W; Hartenstein R; Sauer H; Binsack T
    Gynakol Rundsch; 1981; 21 Suppl 2():9-22. PubMed ID: 7319304
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.
    Parnes HL; Cirrincione C; Aisner J; Berry DA; Allen SL; Abrams J; Chuang E; Cooper MR; Perry MC; Duggan DB; Szatrowski TP; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1819-24. PubMed ID: 12721259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.
    Greco FA; Hainsworth JD
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
    Merlini L; Secondo V; Mammoliti S; Bellotti P; Castello C; Gallo L
    Anticancer Res; 1994; 14(3B):1423-6. PubMed ID: 8067717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phase II study: some reflections, particularly concerning disseminated breast cancer.
    Ahmann DL
    Cancer Chemother Rep 3; 1972 May; 3(1):29-32. PubMed ID: 5049705
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971.
    Coudert B; Focan C; Genet D; Giacchetti S; Cvickovic F; Zambelli A; Fillet G; Chollet P; Amoroso D; Van Der Auwera J; Lentz MA; Marreaud S; Baron B; Gorlia T; Biville F; Lévi F
    Chronobiol Int; 2008 Sep; 25(5):680-96. PubMed ID: 18780198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of 5-fluorouracil in the treatment of advanced breast cancer.
    Ahmann DL; Bisel HF; Hahn RG
    Mayo Clin Proc; 1967 Apr; 42(4):193-9. PubMed ID: 6021841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.